(1) Background: although most patients with epithelial ovarian cancer (EOC) undergo
radical surgery, patients with early-stage disease, borderline ovarian tumor (BOT) or a non …

Surgical staging should always be performed. It includes peritoneal samplings (peritoneal
washing, multiple peritoneal biopsies, omental biopsy and biopsy of any suspicious area) …

Objective To synthesize the evidence on Sertoli–Leydig cell tumour (SLCT) relapses, and
identify the clinicopathological characteristics and prognosis of patients with recurrent SLCT …

Objective: This study aimed to present our single-center clinical experience regarding tumor
clinicopathologic features, treatment modalities, and reproductive and oncologic outcomes …

Sertoli-Leydig cell tumours (SLCTs) represent a rare cause of hyperandrogenic state. SLCTs
are sex cord ovarian neoplasms, accounting for< 0.2% of all ovarian tumours. Most of the …

Sertoli-Leydig cell tumors (SLCT) are a rare form of sex cord stromal tumors. DICER1
germline mutations have been identified in a portion of these cases. We report a 15-year-old …

国际生殖健康/计划生育杂志2022年7月第41卷第4期JIntReprodHealth /FamPlan,July2022 ,
Vol.41 , No.4 Page 1 国际生殖健康/计划生育杂志2022年7月第41卷第4期JIntReprodHealth/FamPlan,July2022 …

Sertoli-Leydig cell tumours (SLCTs) represent a subset of mixed sex cord-stromal tumours
(SCSTs), a rare form of non-epithelial ovarian tumours comprising less than 7% of malignant …

Abstract Ovarian Sertoli-Leydig cell tumors (SLCT) are extremely rare malignant tumors
deriving from the sex cord stroma. An abdominal mass and a virilization syndrome dominate …

Abstract [eng] Leydig cell ovarian tumours are rare ovarian steroid cell neoplasms. More
than 50 percent of patients are concerned with virilization symptoms such as, alopecia …